Investigative report by Mary Beth Pfeiffer of the Poughkeepsie Journal on the lack of balance, conflicts of interest, and the lack of patient representation on the IDSA Guidelines Review Panel. Please like, comment, and share this article, as we need to bring national attention to this issue.
KarlaL
VIDEO: Review of Lyme disease treatment leaves out patients
Mary Beth Pfeiffer Poughkeepsie Journal 9:54 p.m. EDT May 30, 2015
She comes from a state with fewer than 10 Lyme disease cases a year. She has not been involved in Lyme disease causes, but rather in funding cancer research.
Yet she has been named "consumer representative" on a panel that will rewrite treatment guidelines for a tick-borne illness with 20,000 reported cases in the mid-Hudson Valley from 2007 to 2013 — and 300,000 nationwide annually. This while federal standards say the panel should include not one but two people to represent the public: "a current or former patient and a patient advocate."